🇺🇸 FDA
Patent

US 9901619

Compositions comprising PEDF and uses of same in the treatment and prevention of ovary-related syndromes

granted A61KA61K38/18A61K38/24

Quick answer

US patent 9901619 (Compositions comprising PEDF and uses of same in the treatment and prevention of ovary-related syndromes) held by The Fund for Medical Research, Development of Infrastructure and Health Services—Assaf HaRofeh Medical Center expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Fund for Medical Research, Development of Infrastructure and Health Services—Assaf HaRofeh Medical Center
Grant date
Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/18, A61K38/24, A61K38/57, A61P